Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
Abstract In the absence of a correlate(s) of protection against human tuberculosis and a validated animal model of the disease, tools to facilitate vaccine development must be identified. We present an optimised ex vivo mycobacterial growth inhibition assay (MGIA) to assess the ability of host cells...
Guardado en:
Autores principales: | Hannah Painter, Satria A. Prabowo, Felipe Cia, Lisa Stockdale, Rachel Tanner, Samuel Willcocks, Rajko Reljic, Helen A. Fletcher, Andrea Zelmer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e428b49b409439e8ebb3565742e632f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
por: Christina Jensen, et al.
Publicado: (2017) -
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: Matthew K. O’Shea, et al.
Publicado: (2018) -
Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
por: Eileen McNeill, et al.
Publicado: (2018) -
Isolation and enrichment of mouse splenic T cells for ex vivo and in vivo T cell receptor stimulation assays
por: Clémence Grosjean, et al.
Publicado: (2021) -
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
por: Megan C. Cox, et al.
Publicado: (2021)